The in vivo susceptibility of Leishmania donovani to sodium stibogluconate is drug specific and can be reversed by inhibiting glutathione biosynthesis

K.C. Carter, S. Sundar, C. Spickett, O.C. Pereira, A.B. Mullen

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'The in vivo susceptibility of Leishmania donovani to sodium stibogluconate is drug specific and can be reversed by inhibiting glutathione biosynthesis'. Together they form a unique fingerprint.

Medicine & Life Sciences